Can-Fite BioPharma (CANF) Market Capitalization (2016 - 2026)

Can-Fite BioPharma (CANF) has 11 years of Market Capitalization data on file, last reported at $2.4 million in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization fell 99.79% year-over-year to $2.4 million; the trailing twelve-month figure through Jun 2026 stood at $2.4 million (down 99.79% YoY), and the FY2025 full-year result was $3.3 million, down 99.81% from the prior year.
• Market Capitalization was $2.4 million for Q2 2026 at Can-Fite BioPharma, down from $3.3 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $3.4 billion in Q1 2022 to a low of $2.4 million in Q2 2026.
• A 5-year average of $1.5 billion and a median of $1.5 billion in 2023 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization jumped 40.09% in 2024 and slumped 99.81% in 2025, its largest moves.
• Can-Fite BioPharma's Market Capitalization stood at $2.5 billion in 2022, then plunged by 39.88% to $1.5 billion in 2023, then increased by 18.56% to $1.8 billion in 2024, then slumped by 99.81% to $3.3 million in 2025, then decreased by 25.75% to $2.4 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $2.4 million in Q2 2026, $3.3 million in Q4 2025, and $1.1 billion in Q2 2025.